Mukositis/Periimplantitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - ages=18. - Subjects with at least one implant with peri-implantitis. The peri-implantitis is defined as: PPD of 4-6mm combined with BOP+, and bone loss of 2-4mm on peri-apical radiographs (taken by paralleling technique with splints for reproducible X-rays) compared to the time point of restoration placement. - Availability for the 12 month duration of the study - Signed Informed Consent Form.
Exclusion criteria
Exclusion criteria: - Subject with severe systemic diseases. (e.g. uncontrolled hypertension, uncontrolled diabetes, severe coagulation disorder, acute hepatitis, acute nephritis and myocardial infarction history less than 6 months). - Pregnant or lactating females - Patients have history of periodontitis - Patients have history of receiving bisphosphonate therapy - Peri-implant mucositis defined as the absence of radiographic marginal bone loss between restoration placement and pre-screening review - Subjects treated for >2 weeks with any medication known to affect soft tissue condition (e.g. phenytoin, calcium antagonists, cyclosporin, Coumadin and non-steroidal anti-inflammatory drugs) within 1 month of the prescreening examination - Allergy to dye phenothiazine chlorid (“Toloniumchlorid or Toluidinblue“) or mouth rinse with chlorhexidine - Unwilling to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At baseline and after 12months: MBL: marginal bone loss - clinical record | — |
Secondary
| Measure | Time frame |
|---|---|
| At baseline and each 3months-visit during 12months: BOP%: percentage of bleeding on probing - clinical record PPD: pocket probing depth in mm - clinical record Peri-implant bacteria profile - clincal record | — |
Countries
China, Germany
Contacts
Klinik für Zahnerhaltung und Parodontologie im UKSH, Campus Kiel